Edison, NJ, United States of America

Mariappan Chelliah




Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 2003-2017

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: Innovations and Contributions of Mariappan Chelliah

Introduction: Mariappan Chelliah, based in Edison, NJ, is a notable inventor with a total of 19 patents to his name. His work primarily focuses on pharmaceutical compounds and their applications in treating various diseases. His innovative contributions have significantly impacted the fields of medicine and pharmacology.

Latest Patents: Among his latest patents are the "Substituted spiropiperidinyl compounds useful as GPR120 agonists." This invention relates to a compound represented by a specific formula and its pharmaceutically acceptable salts, which are disclosed as useful in treating or preventing diabetes, hyperlipidemia, obesity, and inflammation-related disorders. The compounds act as agonists of the G-protein coupled receptor GPR120, and comprehensive pharmaceutical compositions and treatment methods are included.

Another significant patent is focused on "HCV NS3 protease inhibitors." This invention addresses hepatitis C virus (HCV) NS3 protease inhibitors containing a spirocyclic moiety. The patent covers the uses and synthesis of such compounds, further contributing to potential treatments for hepatitis C.

Career Highlights: Throughout his career, Mariappan has worked with reputable organizations in the pharmaceutical industry, including Schering Corporation and Merck Sharp & Dohme Corporation. His experience at these companies has allowed him to leverage his expertise in drug discovery and development.

Collaborations: Collaboration is an essential aspect of innovation, and Mariappan has worked alongside notable colleagues, including Samuel Chackalamannil and Yan Xia. Their teamwork has fostered advancements in developing therapeutics aimed at tackling various health disorders.

Conclusion: Mariappan Chelliah's contributions as an inventor have been invaluable, particularly in the pharmaceutical domain. With his extensive patent portfolio and collaborative efforts, he continues to advance innovative solutions that address critical health challenges. His work serves as an inspiration in the field of research and development, demonstrating the potential of focused research and creativity in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…